TITLE

All The Little Things�

PUB. DATE
November 2008
SOURCE
LabTalk;Nov/Dec2008, Vol. 36 Issue 23G, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article explores the increasing operation costs of maintaining the business viability of medical laboratories in the U.S. While laboratories in the U.S. are absorbing these increases through revenues, many in the industry are of the opinion that the biggest cost increases are in the are of shipping and transportation being felt around the world. The impact of environmental regulations, wastewater and hazardous waste removal, workman's compensation and employee rights on expense on the income statement is discussed.
ACCESSION #
35359611

 

Related Articles

  • The 2009 Report on Hybrid-Type Flotation Sleep System Ensembles and Mattresses Excluding Conventional Waterbeds: World Market Segmentation by City. Parker, Philip M. // City Segmentation Reports;1/ 9/2010, pN.PAG 

    A report that summarizes the economic potential for major cities in more than 200 countries around the globe for hybrid-type flotation sleep system ensembles and mattresses for the year 2009 is presented. It provides latent demand or potential industry earnings (PIE) estimates for the product...

  • The 2009 Report on Hydrotherapy Appliances: World Market Segmentation by City. Parker, Philip M. // City Segmentation Reports;1/ 9/2010, pN.PAG 

    A report that summarizes the economic potential for major cities in more than 200 countries around the globe for hydrotherapy appliances for the year 2009 is presented. It provides latent demand or potential industry earnings (PIE) estimates for the product for each city. The estimates were...

  • TOP STORIES.  // MondayMorning;11/5/2007, Vol. 15 Issue 44, p1 

    This section offers news briefs relevant to the health care industry. A report forecasts that U.S. pharmaceutical sales will increase at the slowest rate in 44 years in 2008 as cheap generic drugs drive down prices and doctors limit use of medicines tied to harmful side effects. Net profit of...

  • Cardinal Health, Inc. SWOT Analysis.  // Cardinal Health, Inc. SWOT Analysis;5/13/2013, p1 

    The article presents a strengths, weaknesses, opportunities and threats (SWOT) analysis for health care products and services provider Cardinal Health Inc. Its financial performance in the fiscal year ended June 2012 is described. Strengths include an enhanced U.S. pharmaceuticals business due...

  • Medical device firms' earnings increase despite delays in new technology approval. Martinez, Marialba // Caribbean Business;10/31/2002, Vol. 30 Issue 44, p17 

    Reports on the financial performance of medical device manufacturers in Puerto Rico. Net income growth of Johnson & Johnson; Net income of Boston Scientific Corp.; Cardiac Rhythm Management's fiscal second-quarter 2002 sales; Earnings-per-share estimates for Medtronic.

  • SWOT Analysis.  // Apria Healthcare Group SWOT Analysis;Jun2008, p5 

    A business analysis of Apria Healthcare Group Inc., a company which provides a range of home healthcare services, is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths include benefits derived from its strong network facilities....

  • Key Facts.  // Gambro AB SWOT Analysis;Jan2008, p4 

    Key facts about Gambro AB, a global medical technology company developing and supplying products, therapies and services for both in-center and home dialysis, are presented. Address and contact information is given, as well as statistics on revenues, financial year end data and the number of...

  • Key Facts.  // C. R. Bard, Inc. SWOT Analysis;May2007, p4 

    Key facts about C.R. Bard Inc., a company engaged in designing, manufacturing, packaging, distributing and sale of medical, surgical, diagnostic and patient care devices, are presented. Address and contact information is given, as well as statistics on revenues, financial year end data and...

  • Company Overview.  // Allergan, Inc. SWOT Analysis;May2007, p4 

    An overview of Allergan Inc., a global health care company engaged in discovery, development and commercialization of specialty pharmaceutical and medical device products, is presented. Data is included on revenues generated in fiscal year ended December 2006, as well as principal business...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics